-
There is an obvious ethical reason why AIDS Drug Assistance Programs (ADAPs) should prioritize client services according to treating the sickest first. However, a researcher also finds a public health and economic reason for such a change.
-
n this issue: Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions.
-
The risks for illness acquired during travel are greater in immunocompromised travelers.
-
Faced with limited data about acute mountain sickness in children traveling rapidly to high altitude, Swiss researchers studied symptoms in 48 children (ages 10-17, mean age 13) who traveled 2 ½ hours from low altitude (568 meters) to 3450 meters (approximately 11,200 feet).
-
Influenza activity has been relatively low thus far in the 2008-2009 season in the United States.
-
Diffuse lepromatous leprosy (DLL) is an especially virulent form of multibacillary disease, occasionally seen in patients from Central and South America and Southeast Asia. Lucio's phenomena is a highly anergic and more severe form of DLL, resulting in extensive skin and subcutaneous involvement, with an abundance of organisms infiltrating tissues.
-
At the 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene in New Orleans, Louisiana, held from December 7-11, 2008, the Centers for Disease Control and Prevention presented malaria and travel vaccine updates.
-
On Dec. 30, 2008, the Food and Drug Administration (FDA) approved the first nucleic acid test (NAT) that screens for the presence of two divergent types of HIV in donated blood plasma and human tissue.
-
Strong evidence was found that slow gait speed, low physical activity, and weight loss are key indicators of frailty, which is associated with chronic disability, long-term nursing home stays, injurious falls, and death.
-
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.